OBAT Stock Overview

PT Brigit Biofarmaka Teknologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. More details

OBAT fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	0/6
Past Performance	3/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 10.5% below our estimate of its fair value

Earnings grew by 67.9% over the past year

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap (IDR357B)

My Notes

Capture your thoughts, links and company narrative

PT Brigit Biofarmaka Technologi Tbk Competitors

Estee Gold Feet

IDX:EURO

Rp356.8b

Ikapharmindo Putramas

IDX:IKPM

Rp454.9b

Kino Indonesia

IDX:KINO

Rp1.7t

Victoria Care Indonesia

IDX:VICI

Rp4.1t

Price History & Performance

Summary of share price highs, lows and changes for Brigit Biofarmaka Technologi
Historical stock prices
Current Share Price	Rp595.00
52 Week High	Rp600.00
52 Week Low	Rp384.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	36.47%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	OBAT	ID Personal Products	ID Market
7D	n/a	-1.3%	-0.04%
1Y	n/a	6.9%	6.4%

Return vs Industry: Insufficient data to determine how OBAT performed against the ID Personal Products industry.

Return vs Market: Insufficient data to determine how OBAT performed against the ID Market.

Price Volatility

Is OBAT's price volatile compared to industry and market?
OBAT volatility
OBAT Average Weekly Movement	n/a
Personal Products Industry Average Movement	3.9%
Market Average Movement	5.7%
10% most volatile stocks in ID Market	13.3%
10% least volatile stocks in ID Market	2.6%

Stable Share Price: OBAT's share price has been volatile over the past 3 months compared to the ID market.

Volatility Over Time: Insufficient data to determine OBAT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2015	35	Is Heriyanto	www.brigit.co.id

PT Brigit Biofarmaka Teknologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, hair serum, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products. The company was founded in 2015 and is based in Sukoharjo, Indonesia.

PT Brigit Biofarmaka Technologi Tbk Fundamentals Summary

How do Brigit Biofarmaka Technologi's earnings and revenue compare to its market cap?
OBAT fundamental statistics
Market cap	Rp357.00b
Earnings (TTM)	Rp20.46b
Revenue (TTM)	Rp92.44b

17.5x

P/E Ratio

3.9x

P/S Ratio

Is OBAT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OBAT income statement (TTM)
Revenue	Rp92.44b
Cost of Revenue	Rp55.24b
Gross Profit	Rp37.20b
Other Expenses	Rp16.74b
Earnings	Rp20.46b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	34.09
Gross Margin	40.24%
Net Profit Margin	22.13%
Debt/Equity Ratio	7.8%

How did OBAT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/19 10:53
End of Day Share Price	2025/01/17 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PT Brigit Biofarmaka Technologi Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution